Sleep apnea is worth screening only by trigger, not as a blind test. Known baseline STOP-BANG points are age >50 and male sex; BMI is about 24, and the cloud doc does not document habitual snoring, witnessed apneas, daytime sleepiness, or hypertension yet. The cheap path is to finish the home BP profile, use Apple Watch sleep/SpO2/breathing-disturbance trends as weak triage signals, and ask about snoring/witnessed apnea. If repeated morning BP elevation, supported-watch sleep-apnea notifications, repeated nocturnal SpO2/breathing disturbance, or classic symptoms appear, Royal Phnom Penh Hospital publicly lists sleep specialist care plus in-lab and home sleep apnea testing. A positive result would mainly change BP/autonomic-risk handling and treatment priority; it would not replace CAC/CCTA/echo or justify treating watch data as a diagnosis.
sleep-apnea · nocturnal-hypoxia · blood-pressure · apple-watch · hsat · cardiovascular · lpa
Classification: INTEGRATE. The active queue item needs a compact standalone router because it connects home BP, Apple Watch sleep signals, local sleep-test logistics, and the high-Lp(a) cardiovascular risk plan.
Current call: do not buy or book a sleep test blindly. Use trigger-based screening first. In this profile the already-known STOP-BANG points are age >50 and male sex; BMI is about 24, and the cloud doc does not document loud habitual snoring, witnessed apneas, daytime sleepiness, or confirmed hypertension. That is not enough to diagnose or strongly suspect OSA.
| Trigger | Meaning | Action |
|---|---|---|
| STOP-BANG known score only 2 from age + male, with BMI ~24 and no symptoms | Low-to-uncertain pretest probability | Do not screen just to screen; finish BP and symptom check first. |
| Habitual loud snoring, witnessed apneas, choking/gasping, unrefreshing sleep, or daytime sleepiness | Classic OSA symptom cluster | Use STOP-BANG/Epworth as triage, then objective testing if risk is moderate/high. |
| 7-day home BP shows repeated morning elevation or average >=130/80, especially >=135/85 | OSA becomes more relevant because OSA often worsens BP and nocturnal/morning BP patterns | Consider ABPM and/or sleep consultation; ask specifically about nocturnal BP/non-dipping if ABPM is available. |
| Apple Watch supported-model sleep-apnea notification or repeated elevated breathing disturbances over 30 days | Useful prompt, not a diagnosis | Export/share the PDF with a clinician; use it to justify HSAT/PSG, not to self-treat. |
| Repeated nocturnal SpO2 clusters clearly low or respiratory-rate anomalies with symptoms | Triage signal, device-noisy | Repeat/confirm with better data; if persistent, ask for HSAT or PSG. Single-night dips are not enough. |
| Resistant hypertension, atrial fibrillation, pulmonary hypertension, stroke/TIA, heart failure, or coronary disease appears later | High-value cardiovascular indication | Sleep screening moves up even without classic sleep complaints. |
| HSAT negative/inconclusive but suspicion remains high | HSAT can miss or underestimate disease | Ask for in-lab polysomnography rather than dropping the branch. |
AASM diagnostic guidance is the anchor: questionnaires and prediction tools should not diagnose OSA without objective sleep testing; HSAT is appropriate for uncomplicated adults with signs/symptoms suggesting moderate-severe OSA, while PSG is preferred when comorbidities or inconclusive HSAT results make home testing unreliable. USPSTF gives an insufficient-evidence statement for screening asymptomatic adults, so this branch should be trigger-based rather than universal screening.
The cardiovascular rationale is real but should not be inflated. The AHA statement describes OSA as intermittent hypoxemia, autonomic fluctuation, and sleep fragmentation, with high prevalence in hypertension and cardiovascular disease. STOP-BANG is useful for triage because sensitivity is high, but specificity is modest; it is a “who should be tested?” tool, not a diagnosis. CPAP meta-analyses show small average BP reductions and larger reductions in resistant hypertension, while cardiovascular outcome trials such as SAVE did not show broad event prevention from CPAP on top of usual care. That makes symptom/BP/autonomic improvement the near-term target.
Local logistics are better than expected: Royal Phnom Penh Hospital has public sleep-apnea pages describing a sleep lab, sleep specialist consultation, in-lab polysomnography, and HSAT. Roomchang Dental Hospital advertises a home-monitoring plus oral-appliance pathway; treat that as a dental-treatment route after diagnostic clarity, not the first medical workup for cardiovascular-risk interpretation.